Clinical Trials

Search for trials
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Biological
  • Participants: 300
  • Start Date: October 2021
HEPLISAV-B Pregnancy Registry: An Observational Study on the Safety of HEPLISAV-B Exposure in Pregnant Women and Their Offspring
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 5
  • Start Date: October 1, 2021
Phase 1 Safety and Tolerability Study of Redirected HBV-Specific T Cells in Patients With Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (SAFE-T-HBV)
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 200
  • Start Date: October 2021
Emergency Department Patient's Perceptions and Acceptability Toward a Novel Point-of-Care Hepatitis C Virus Viral Load Testing
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug, Other
  • Participants: 280
  • Start Date: August 2021
A Multicenter, Open-label, Randomized Controlled Trial to Safely Discontinue Antiviral Treatment in Patients With Chronic Hepatitis B (ADAPT)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 400
  • Start Date: August 2021
A Multicenter, Open-label, Randomized Controlled Trial for the Effectiveness of Antiviral TreAtment in Cirrhotic Patients With Low-level Hepatitis B Virus DNA Levels (ATTACH)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 90
  • Start Date: July 2021
Controlled Interruption of Nucleos(t)Ide Analogue Treatment in Chronic Hepatitis B Patients - a Cost-benefit Analysis and Assessment of the Role of Ethnicity
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 60
  • Start Date: July 2021
Evaluation of Novel Point of Care Hepatitis B Diagnostic Assays
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 36
  • Start Date: June 1, 2021
U01 Pilot Trial of DUR-928 in Patients With Moderate and Severe Alcoholic Hepatitis
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 308
  • Start Date: June 2021
Use of a Patient-Centered Electronic App to Increase Emergency Department Patient's Knowledge on HCV Infection, Disease Progression, and Care to Improve the HCV Care Continuum
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 4000
  • Start Date: May 2021
A Multi-centre, Practice-level, Cluster Randomized, Parallel-group Controlled Trial to Compare Point-of-care Hepatitis C RNA Testing to Dried Blood Spot Testing to Enhance Treatment Uptake Among People With HCV Who Have Recently Injected Drugs Attending Needle and Syringe Programs: the TEMPO Study
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 160
  • Start Date: May 1, 2021
Impact of Rapid ART Initiation on Retention in Care in the Southern US
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 500
  • Start Date: May 2021
A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients
Showing 1-12 of 794